Kian Santang Muliatama Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Kian Santang Muliatama Tbk. trades at Rp214 (market cap 315.19B, 8.5M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 2.4× Kian Santang Muliatama Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 8.5M). Which is the better fit depends on your goals.
| RGAS | RSCH | |
|---|---|---|
Market Cap | 315.19B | 742B |
Volume | 8.5M | 29.45M |
Lot | 84.96K | 294.49K |
Turnover | 1.82B | 8.14B |
Average Price | 214.14 | 276.35 |
Value | 1.82B | 8.14B |
Indicative Equilibrium Price | 214 | 270 |
Indicative Equilibrium Volume | 893 | 103 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →